Export

ATC codes: J05AH02
EMLc
Indication
Influenza due to seasonal identified influenza virus ICD11 code: 1E30
INN
Oseltamivir
Medicine type
Chemical agent
List type
Complementary *severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.
Formulations
Oral > Liquid: 12 mg per mL powder for oral liquid
Oral > Solid: 30 mg capsule (as phosphate) ; 45 mg capsule (as phosphate) ; 75 mg capsule (as phosphate)
EML status history
First added in 2011 (TRS 965)
Changed in 2013 (TRS 985)
Changed in 2017 (TRS 1006)
Changed in 2019 (TRS 1021)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Committee noted the advice from the WHO Secretariat that the WHO Guidelines for clinical management of influenza are in the process of being updated, but the recommendations of the guideline development group were not yet available. The Committee recommended that no change be made to the current listing for oseltamivir on the Model Lists until the updated guidelines and supporting evidence can be reviewed.